Skip to content

Interest of Audiovisual Distraction in the Management of Anxiety and Pain During Oocyte Retrieval

Does Audiovisual Distraction Decrease the Use of Hypnotic Drugs During Oocyte Retrieval?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04213781
Acronym
Happy-Fiv
Enrollment
36
Registered
2019-12-30
Start date
2020-09-23
Completion date
2020-11-25
Last updated
2026-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertilization in Vitro

Keywords

Oocyte retrieval, Sedation

Brief summary

Oocyte retrieval procedure for in vitro fertilization is a source of anxiety for patients. Local anaesthesia or sedation are commonly used to manage many situations of anxiety, including the oocyte retrieval. However, this sedation should be as mild as possible in order to preserve oocytes. HappyMed Video Glasses are a recent medical device that allows the immersion of patients in films, cartoons or concerts. By distracting patients, this technology can reduce anxiety, discomfort and ultimately pain associated with care. This randomized monocentric trial compares audiovisual distraction versus usual care for the management of anxiety and pain related to oocyte retrieval. Hypothesis of this study is that the audiovisual distraction carried out with the HappyMed Video Glasses reduces the use of sedative drugs during oocyte retrieval while ensuring a better comfort and a faster walking ability.

Detailed description

Consent female patients between 18 and 43 years old scheduled for oocyte retrieval will be enrolled in this study and their anxiety level will be collected via a questionnaire. After randomization, patients will either benefit from audiovisual distraction using HappyMed Video Glasses, (medical device with CE marking), or from the usual management during procedure. The anaesthesiologist will check that no anxiolytic or sedative drug was given 12 hours before anaesthesia. The patients will be stratified according to whether or not a previous intervention was performed. Anaesthesia will be started and maintained with administration of sufentanil (0.1 μg/kg) and propofol (using the Dixon's up-and-down method). The aim is a patient who spontaneously ventilates and does not react to gynaecological stimulation. Prevention of postoperative pain and nausea/vomiting will be carried out at the initiation of the surgical procedure. The effect of these drugs is longer than the intervention duration and will not influence the protocol.

Interventions

DEVICEHappyMed Video Glasses

HappyMed allows the immersion of patients in films, cartoons or concerts.

DRUGPropofol

The dosage is modified according to the Dixon's up-and-down method (using 0.5 µg/ml as a step size). The first patient in each group will start at a dose 3 µg/ml propofol. If patient manifests discomfort then the next patient will receive an increment of 0.5 µg/ml propofol, if patient is comfortable, then the next patient received a decrement of 0.5 µg/ml propofol.

DRUGSufentanil

0.1 µg/kg

Sponsors

CMC Ambroise Paré
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing oocyte retrieval requiring a sedation associating sufentanil and propofol * Contactable by phone the day after the procedure. * Consent for participation * Affiliation to the social security system

Exclusion criteria

* Corneal or conjunctival diseases in progress, * Claustrophobia * Patients under protection of the adults (guardianship, curators or safeguard of justice) * Communication difficulties or neuropsychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
Target concentration of propofol administered during oocyte retrieval procedure to maintain the patient comfortableIntraoperative period : from the start of anaesthesia to the end of the interventionAn up and down method will define the CP 50 in each group.

Secondary

MeasureTime frameDescription
Side effects due to audiovisual distraction4 hoursOnset of vertigo, nausea or headaches
Patient comfort during propofol injection30 minutesComfort behavior scale : it incorporates three categories of behavior : Facial expression (0=relaxed ; 1= frowning ; 2=grimacing) ; Verbal response (0=none ; 1= moans ; 2=verbal protest) ; Arm movement (0=none ; 1=medium ; 2=strong). Each scored on a 0-2-point scale so that the total score ranges from 0 to 6.
Complications due to anaesthesiaup to 24 hours (from the start of anaesthesia to the patient's discharge of the recovery room)Occurence of desaturation event (SpO2\< 92%), respiratory distress event (RR\<10 breaths per minute) or bronchospasm.
Resumption of walking12 hoursDuration between the end of the procedure and the standing position.
Health staff satisfaction2 hoursSatisfaction VRS ranging from 0 to 4 (0=unsatisfied, 4=very satisfied).
Patient satisfaction4 hoursSatisfaction VRS ranging from 0 to 4 (0=unsatisfied, 4=very satisfied).
Resuming activities of daily living24 hoursNumeric scale from 0 to 10 (0=bedridden, 10=resuming total activities).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 9, 2026